Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
Samuel Cass(The University of Texas MD Anderson Cancer Center), Joshua W.D. Tobin(The University of Queensland), Yongwoo David Seo(The University of Texas MD Anderson Cancer Center), Georgina Gener‐Ricos(The University of Texas MD Anderson Cancer Center), Emily Z. Keung(The University of Texas MD Anderson Cancer Center), Elizabeth M. Burton(The University of Texas MD Anderson Cancer Center), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Jennifer L. McQuade(The University of Texas MD Anderson Cancer Center), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Robert M. Mason(Gold Coast Hospital), Michael Millward(The University of Western Australia), Shahneen Sandhu(Peter MacCallum Cancer Centre), Chloe Khoo(Peter MacCallum Cancer Centre), Lydia Warburton(Edith Cowan University), Veronica Guerra(The University of Texas MD Anderson Cancer Center), Andrew Haydon(The Alfred Hospital), Helen Clare Dearden(The University of Sydney), Alexander M. Menzies(Mater Hospital), Matteo S. Carlino(Westmead Hospital), Jessica L. Smith(Westmead Hospital), Peter Mollee(The University of Queensland), Melinda Burgess(The University of Queensland), Sally Mapp(The University of Queensland), Colm Keane(The University of Queensland), Victoria Atkinson(The University of Queensland), Sameer A. Parikh(Mayo Clinic in Florida), Svetomir N. Markovic(Mayo Clinic in Florida), Wei Ding(Mayo Clinic in Florida), Timothy G. Call(Mayo Clinic in Florida), Paul J. Hampel(Mayo Clinic in Florida), Georgina V. Long(The University of Sydney), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Alessandra Ferrajoli(The University of Texas MD Anderson Cancer Center)
Cited by 12Open Access